Cargando…

COVID-19 Impact on Chronic Myeloid Leukemia Patients

(1) Background: Chronic myeloid leukemia (CML) is a blood dyscrasia that accounts for about 20% of all leukemia cases. Tyrosine kinase inhibitors (TKIs) are used as first line treatment of CML. The 2019 SARS-CoV-2 outbreak raised new concerns for CML patients, such as whether CML increases the risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arbore, Dana Raluca, Galdean, Simona Maria, Dima, Delia, Rus, Ioana, Kegyes, David, Ababei, Raluca Geanina, Dragancea, Daniela, Tomai, Radu Andrei, Trifa, Adrian Pavel, Tomuleasa, Ciprian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699250/ https://www.ncbi.nlm.nih.gov/pubmed/36573722 http://dx.doi.org/10.3390/jpm12111886

Ejemplares similares

PB1900: COVID-19 IMPACT ON CHRONIC MYELOID LEUKEMIA PATIENTS
por: Galdean, S.-M., et al.
Publicado: (2022)

A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience
por: Jimbu, Laura, et al.
Publicado: (2023)

Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia
por: Dobrowolski, Jerome, et al.
Publicado: (2019)

Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR–ABL transcripts
por: Dima, Delia, et al.
Publicado: (2017)

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
por: Petrushev, Bobe, et al.
Publicado: (2016)

Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
por: Moisoiu, Vlad, et al.
Publicado: (2019)

A narrative review of central nervous system involvement in acute leukemias
por: Deak, Dalma, et al.
Publicado: (2021)

Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient Following Therapy with Ixazomib-Lenalidomide-Dexamethasone
por: Constantinescu, Catalin, et al.
Publicado: (2022)

Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia
por: Tigu, Adrian Bogdan, et al.
Publicado: (2023)

Modelling the Effects of MCM7 Variants, Somatic Mutations, and Clinical Features on Acute Myeloid Leukemia Susceptibility and Prognosis
por: Tripon, Florin, et al.
Publicado: (2020)

Paraneoplastic hypereosinophilia in a patient with peripheral T cell lymphoma, not otherwise specified
por: Desmirean, Minodora, et al.
Publicado: (2019)

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2014)

Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities
por: Aanei, Carmen-Mariana, et al.
Publicado: (2021)

The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia
por: Jimbu, Laura, et al.
Publicado: (2021)

Outcomes of CAR-T Cell Therapy Recipients Admitted to the ICU: In Search for a Standard of Care—A Brief Overview and Meta-Analysis of Proportions
por: Constantinescu, Catalin, et al.
Publicado: (2023)

Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease
por: Iluta, Sabina, et al.
Publicado: (2022)

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
por: Turcas, Cristina, et al.
Publicado: (2020)

Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies
por: Kojima, Seiji, et al.
Publicado: (2014)

Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
por: Simon, Timea, et al.
Publicado: (2015)

Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
por: Kegyes, David, et al.
Publicado: (2022)

TET2 rs1548483 SNP Associating with Susceptibility to Molecularly Annotated Polycythemia Vera and Primary Myelofibrosis
por: Lighezan, Diana L., et al.
Publicado: (2020)

Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician
por: Constantinescu, Catalin, et al.
Publicado: (2019)

The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients
por: Pasca, Sergiu, et al.
Publicado: (2020)

Nigella sativa: Valuable perspective in the management of chronic diseases
por: Pop, Raluca Maria, et al.
Publicado: (2020)

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
por: Iluta, Sabina, et al.
Publicado: (2021)

Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia
por: Bănescu, Claudia, et al.
Publicado: (2019)

CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 Genetic Polymorphisms in Chronic Myeloid Leukemia: A Case-Control Study
por: Bănescu, Claudia, et al.
Publicado: (2014)

Targeting the Microenvironment in MDS: The Final Frontier
por: Teodorescu, Patric, et al.
Publicado: (2020)

Long Non-coding RNAs in Myeloid Malignancies
por: Zimta, Alina-Andreea, et al.
Publicado: (2019)

Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study
por: Tripon, Florin, et al.
Publicado: (2020)

TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020)

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
por: Tomuleasa, Ciprian, et al.
Publicado: (2018)

MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization
por: Neaga, Alexandra, et al.
Publicado: (2021)

Protein dysregulation in graft versus host disease
por: Qian, Liren, et al.
Publicado: (2017)

The Effect of Different Anesthetic Techniques on Proliferation, Apoptosis, and Gene Expression in Colon Cancer Cells: A Pilot In Vitro Study
por: Alexa, Alexandru Leonard, et al.
Publicado: (2023)

Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
por: Munteanu, Raluca, et al.
Publicado: (2023)

The use of rotation to fentanyl in cancer-related pain
por: Dima, Delia, et al.
Publicado: (2017)

Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease
por: Tomuleasa, Ciprian, et al.
Publicado: (2015)

Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
por: Tomuleasa, Ciprian, et al.
Publicado: (2013)

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
por: Colita, Andrei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_atqt5vk3rdntdkfkostnn3va75